Guardant Health
GH
#3168
Rank
NZ$6.52 B
Marketcap
$52.80
Share price
0.98%
Change (1 day)
33.44%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company